News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,966 Results
Type
Article (5055)
Company Profile (17)
Press Release (220894)
Section
Business (82412)
Career Advice (463)
Deals (15068)
Drug Delivery (8)
Drug Development (19112)
Employer Resources (30)
FDA (3692)
Job Trends (3905)
News (120414)
Policy (7534)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (300)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14828)
ALS (19)
Alzheimer's disease (253)
Antibody-drug conjugate (ADC) (11)
Approvals (3708)
Artificial intelligence (41)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2866)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (439)
Cardiovascular disease (22)
Career advice (394)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16043)
Collaboration (166)
Compensation (163)
Complete response letters (2)
COVID-19 (306)
CRISPR (7)
C-suite (99)
Cystic fibrosis (16)
Data (509)
Depression (5)
Diabetes (40)
Diagnostics (2041)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40833)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37851)
Executive appointments (305)
FDA (3940)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (186)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (107)
Government (414)
Guidances (16)
Healthcare (5112)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (322)
Inflammatory bowel disease (25)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7840)
IRA (3)
Job creations (1121)
Job search strategy (362)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2335)
Liver cancer (17)
Lung cancer (53)
Lymphoma (28)
Management (10)
Manufacturing (46)
MASH (27)
Medical device (3981)
Medtech (3982)
Mergers & acquisitions (7433)
Metabolic disorders (118)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (347)
NextGen: Class of 2025 (1682)
Non-profit (727)
Northern California (907)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (27)
Partnered (4)
Patents (24)
Patient recruitment (29)
Peanut (5)
People (24658)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4783)
Phase II (6965)
Phase III (5555)
Pipeline (542)
Policy (8)
Postmarket research (626)
Preclinical (1886)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5138)
Reports (14)
Research institute (432)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (26)
Series B (23)
Sickle cell disease (7)
Southern California (688)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1013)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6989)
Vaccines (36)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (5)
Last 7 days (126)
Last 30 days (745)
Last 365 days (10123)
2025 (2856)
2024 (11113)
2023 (13312)
2022 (18784)
2021 (19799)
2020 (18344)
2019 (13317)
2018 (10271)
2017 (10055)
2016 (9205)
2015 (12141)
2014 (9606)
2013 (7721)
2012 (8341)
2011 (8810)
2010 (8637)
Location
Africa (185)
Alabama (13)
Alaska (2)
Arizona (61)
Arkansas (1)
Asia (11498)
Australia (1611)
California (1908)
Canada (689)
China (70)
Colorado (80)
Connecticut (92)
Delaware (29)
Europe (24574)
Florida (267)
Georgia (33)
Idaho (23)
Illinois (111)
India (6)
Indiana (62)
Iowa (1)
Japan (67)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (218)
Massachusetts (1532)
Michigan (85)
Minnesota (138)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (584)
New Mexico (5)
New York (484)
North Carolina (321)
North Dakota (2)
Northern California (907)
Ohio (55)
Oklahoma (5)
Oregon (4)
Pennsylvania (339)
Puerto Rico (1)
Rhode Island (12)
South America (278)
South Carolina (4)
Southern California (688)
Tennessee (38)
Texas (236)
Utah (59)
Virginia (43)
Washington D.C. (9)
Washington State (169)
West Virginia (2)
Wisconsin (21)
225,966 Results for "bioelectronics corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
BioElectronics Corporation a developer of medical technology products, announces the results and publication of a study investigating the efficacy of its FDA-cleared pulsed-shortwave-therapy device in initiating a systemic anti-inflammatory response to improve functionality of canines diagnosed with osteoarthritis.
March 25, 2024
·
4 min read
BioCapital
BioElectronics Corporation Announces the Publication of Pilot Study Results
BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the publication of a study investigating the treatment of phantom and residual limb pain using its pulsed shortwave therapy device.
February 23, 2024
·
4 min read
BioCapital
BioElectronics Chairman Updates Investors
BioElectronics Corporation releases an update from its Chairman, Richard Staelin, PhD.
February 15, 2024
·
8 min read
Press Releases
Feinstein Institutes, Bioelectronic Medicine honor three University of Texas at Dallas researchers with 2024 Cerami Award
February 4, 2025
·
5 min read
Press Releases
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
February 18, 2025
·
7 min read
Pharm Country
Bioelectronic medicine Feinstein Institutes researchers elected to AIMBE College of Fellows
The American Institute for Medical and Biological Engineering has announced the election of two researchers from The Feinstein Institutes for Medical Research to the AIMBE College of Fellows Class of 2024 for their contributions to the fields of medical and biological engineering, and particularly the field of bioelectronic medicine.
March 25, 2024
·
6 min read
Press Releases
Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H’s REACT Program
December 17, 2024
·
6 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Salvia BioElectronics’ Groundbreaking Neuromodulation Solution for Severe Migraine and Cluster Headaches Administered to First Patient
Salvia BioElectronics, a pioneering company focused on neuromodulation for severe migraine, announced the successful first implantation of their paper-thin neuromodulation solution.
July 5, 2023
·
2 min read
Biotech Bay
Tivic Health Funded Study Begins Enrollment for Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation
Tivic Health® Systems, Inc. announced that the research study that the company is funding at The Feinstein Institutes for Medical Research has received study approval from the Institutional Review Board and has initiated study recruitment and enrollment for its novel non-invasive bioelectronic device approach to vagus nerve stimulation.
August 16, 2023
·
4 min read
1 of 22,597
Next
